George B. Abercrombie
Board Member
Biocryst Pharmaceuticals Inc (BCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About George B. Abercrombie
George B. Abercrombie is recorded as Board Member at Biocryst Pharmaceuticals Inc (BCRX). Biocryst Pharmaceuticals Inc reported in an 8-K filed June 16, 2025 that George B. Abercrombie retired as Board of Directors. Biocryst Pharmaceuticals Inc reported in an 8-K filed June 14, 2023 that George B. Abercrombie was appointed director, effective June 13, 2023.
“On June 11, 2025, George B. Abercrombie notified BioCryst Pharmaceuticals, Inc., a Delaware corporation (the "Company"), of his intention to retire from the Board of Directors of the Company (the "Board"), effective as of the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting").”
“The nominees for director were elected by the following votes:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-13–present
-
2011-01-01–2025-06-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biocryst Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Charles Gayer CEO, Board Member
- Charlie Gayer CEO, Board Member
- Jon P. Stonehouse CEO, CFO, Chief Accounting Officer, Board Member
- Vincent J. Milano Chairman, Board Member
- Anthony Doyle CFO
- Babar Ghias CFO, Chief Accounting Officer
- Thomas R. Staab II CFO
- A. Machelle Sanders Board Member
- Alan G. Levin Board Member
- Amy E. McKee Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.